Policlinico San Matteo Pavia Fondazione IRCCS

Hospital


Location: Pavia, Italy (IT) IT

ISNI: 0000000417603027

ROR: https://ror.org/05w1q1c88

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis (2019) Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, et al. Journal article Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: Outcome strongly correlates with disease status; a report from the EBMT acute leukemia working party (2019) Bazarbachi A, Labopin M, Angelucci E, Gulbas Z, Ozdogu H, Arat M, De Rosa L, et al. Conference contribution Management of Malnutrition in Older Patients-Current Approaches, Evidence and Open Questions (2019) Volkert D, Beck AM, Cederholm T, Cereda E, Cruz-Jentoft A, Goisser S, De Groot L, et al. Journal article, Review article RELATIONSHIP BETWEEN ANTI-MDA5 ANTIBODIES AND CANCER: RETROSPECTIVE ANALYSIS OF AN INTERNATIONAL AND MULTIDISCIPLINARY COHORT (2019) De Stefano L, Castaneda S, De Langhe E, Distler J, Knitza J, Cavazzana I, Meyer A, et al. Conference contribution Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort (2019) Wu W, Jordan S, Graf N, Pena JDO, Curram J, Allanore Y, Matucci-Cerinic M, et al. Journal article PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy (2019) Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, et al. Conference contribution Response to: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: Contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al (2019) Knitza J, Cavagna L, Schett G, Distler J Journal article Non-specific gastrointestinal features: Could it be Fabry disease? (2018) Hilz MJ, Arbustini E, Dagna L, Gasbarrini A, Goizet C, Lacombe D, Liguori R, et al. Journal article Proposal of a rating scale to recognize Fabry disease in patients with nonspecific gastrointestinal symptoms (2018) Hilz MJ, Arbustini E, Dagna L, Gasbarrini A, Goizet C, Lacombe D, Liguori R, et al. Conference contribution Do we understand the pathophysiology of gastrointestinal symptoms in patients with Fabry disease? (2018) Hilz MJ, Arbustini E, Dagna L, Gasbarrini A, Goizet C, Lacombe D, Liguori R, et al. Conference contribution